Luo Tiange, Han Jie, Meng Xu
Cardiac Valve Center, Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University-Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing 100029, China.
J Thorac Dis. 2017 Sep;9(9):3138-3147. doi: 10.21037/jtd.2017.08.121.
We aimed to assess the pathological characteristics of rheumatic mitral valve disease in Chinese patients and formulate a pathological grading system to identify cases suitable for rheumatic mitral valve repair (rMVP).
Nearly 5 years of follow-up data on patients who underwent rMVP were analysed. A Kaplan-Meier survival curve for freedom from reoperation and valve failure was constructed. A pathological grading system of rheumatic mitral valve lesions (PGSRMVL) was developed based on the pathological characteristics of rheumatic mitral valve disease and tested by receiver operating characteristics (ROCs) curve analysis. Predictors of endpoints for rheumatic repair were analysed.
From January 2012 to June 2016, 179 patients underwent rMVP in our centre. The mean follow-up duration was 24±14 months. A left atrial anterior and posterior diameter >60 mm was an independent predictor for the 16 endpoints [hazard ratio (HR) =3.884, P=0.029]. Between 2015 and 2016, 126 consecutive pathological characteristics of rheumatic mitral valve were evaluated (61 and 65 repair and replacement cases, respectively). The ROCs area under the curve was 0.891 for the correlation between the pathological score and successful repair (cut-off point, 17.5; sensitivity, 78%; specificity, 85.2%). Seven lesions had higher ratios in the replacement group than the repair group. Commissural fusion/calcification and main chordae tendineae fusion/calcification were the most common severe pathological lesions.
The main pathological characteristics of rheumatic mitral valve disease in Chinese patients are commissure and sub-valvular apparatus lesions. Most patients can be appropriately treated via commissurotomy and leaflet thinning. Severe calcification of the commissure and sub-valvular apparatus can considerably decrease the odds of a successful repair. The median follow-up results of rheumatic mitral repair are considered satisfactory for the pathological characteristics in Chinese patients.
我们旨在评估中国风湿性二尖瓣疾病患者的病理特征,并制定一个病理分级系统,以确定适合风湿性二尖瓣修复术(rMVP)的病例。
分析了近5年接受rMVP患者的随访数据。构建了免于再次手术和瓣膜功能衰竭的Kaplan-Meier生存曲线。基于风湿性二尖瓣疾病的病理特征,建立了风湿性二尖瓣病变病理分级系统(PGSRMVL),并通过受试者工作特征(ROC)曲线分析进行检验。分析了风湿性修复终点的预测因素。
2012年1月至2016年6月,179例患者在本中心接受了rMVP。平均随访时间为24±14个月。左心房前后径>60mm是16个终点事件的独立预测因素[风险比(HR)=3.884,P=0.029]。2015年至2016年,连续评估了126例风湿性二尖瓣的病理特征(修复组和置换组分别为61例和65例)。病理评分与成功修复之间相关性的ROC曲线下面积为0.891(截断点为17.5;敏感性为78%;特异性为85.2%)。置换组中有7种病变的比例高于修复组。瓣叶融合/钙化和主要腱索融合/钙化是最常见的严重病理病变。
中国风湿性二尖瓣疾病患者的主要病理特征是瓣叶和瓣下结构病变。大多数患者可通过瓣叶切开术和瓣叶减薄术得到适当治疗。瓣叶和瓣下结构的严重钙化会显著降低成功修复的几率。对于中国患者的病理特征,风湿性二尖瓣修复的中期随访结果令人满意。